← Back to Search

Dietary Supplement

Nicotinamide mononucleotide (NMN-C) for Healthy Subjects

N/A
Waitlist Available
Research Sponsored by Seneque SA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-dose and at 0.25, 0.5, 1, 2, 4, 8, 12 hour post-dose on day 29
Awards & highlights
No Placebo-Only Group

Summary

This trial studies the safety and effects of NMN-C, a compound that may improve energy and cell health, in healthy adults aged 18-65 over a month.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-dose and at 0.25, 0.5, 1, 2, 4, 8, 12 hour post-dose on day 29
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-dose and at 0.25, 0.5, 1, 2, 4, 8, 12 hour post-dose on day 29 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Safety as measured by subject incident of treatment-emergent adverse events
Safety as measured by subject incident of treatment-emergent clinically significant changes in clinical laboratory safety tests.
Safety as measured by subject incident of treatment-emergent clinically significant changes in vital signs
Secondary study objectives
Change from baseline in NAD+ and NMN concentrations in whole blood
Change from baseline in NAD+ metabolites concentrations in plasma
Change from baseline in NAD+ metabolites concentrations in urine
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: NMN-CExperimental Treatment1 Intervention
Healthy individuals receiving NMN-C
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nicotinamide mononucleotide (NMN-C)
2021
N/A
~50

Find a Location

Who is running the clinical trial?

Seneque SALead Sponsor
3 Previous Clinical Trials
237 Total Patients Enrolled
Dicentra Inc.Industry Sponsor
4 Previous Clinical Trials
384 Total Patients Enrolled
LGDIndustry Sponsor
7 Previous Clinical Trials
518 Total Patients Enrolled
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top